AIM ImmunoTech, Inc. (AIM)
1.318
+0.07
(+5.40%)
USD |
NYAM |
Dec 29, 16:00
1.31
-0.01
(-0.57%)
After-Hours: 20:00
AIM ImmunoTech EPS Diluted (Quarterly): -1.569 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 1.432 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Electromed, Inc. | 0.246 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.284M |
| Revenue (Quarterly) | 0.026M |
| Total Expenses (Quarterly) | 3.31M |
| Enterprise Value | 0.9358M |
| Gross Profit Margin (Quarterly) | -369.2% |
| Profit Margin (Quarterly) | -12.63K% |
| Earnings Yield | -1.13K% |
| Normalized Earnings Yield | -1128.93 |